Physician profile
Dinesh Kumar
NPI 1942239306
$1,267.78
in general payments reported to CMS, 2019-2025
11 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.91 · 2020: $57.95 · 2022: $93.21 · 2023: $275 · 2024: $521 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,020.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $702.01 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $175.59 | 2023 | Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $81.51 | 2022-2024 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $80.55 | 2019-2023 | Farxiga |
| Medtronic USA, INC. | $78.72 | 2019 | |
| Abiomed | $46.15 | 2022 | |
| Janssen Biotech, INC. | $25.77 | 2023 | Symtuza |
| Janssen Pharmaceuticals, INC | $21.09 | 2024 | Xarelto |
| Biotronik INC. | $20.54 | 2020 | |
| Pfizer INC. | $19.36 | 2022 | |
| Medtronic Vascular, INC. | $16.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dinesh Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.